Skip to main content
. 2017 Aug 20;20(8):543–548. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2017.08.07

3.

BIM多态性与短期疗效的差异

Relationship between BIM gene polymorphism and therapeutic efficacy of tyrosine kinase inhibitor

BIM CR PR SD PD ORR (%) P
CR: complete response; PR: partial response; SD: stable dosease; PD: progressive disease; ORR: objective response rate.
Deletion polymorphism 0 4 8 2 28.57 0.557
Non-deletion polymorphism 1 26 36 5 39.71